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Prediction of Caesarean Delivery
Niamh C. Murphy, Fionnuala M. Breathnach 
and Naomi Burke
Abstract
For expectant parents, a first birth is notable for its unpredictability, and the 
path to safe labour and delivery is commonly complicated by a requirement for 
unplanned caesarean delivery. The ability to anticipate an uncomplicated vaginal 
birth, or to predict the requirement for unplanned caesarean delivery, carries the 
potential to facilitate optimal birth choices. For example, elective caesarean deliv-
ery confers substantially less risk than unplanned caesarean delivery performed 
during the course of labour. Pre-delivery knowledge of a high predictive risk of 
requiring intrapartum caesarean delivery could lead to women opting to deliver by 
elective caesarean delivery, thereby lowering associated risks. Equally, pre-labour 
knowledge of a high prospect of achieving a successful and uncomplicated vaginal 
birth could result in enhanced motivation for women to deliver in a less medicalised 
environment. Predictive risk models have been utilised to good effect in other areas 
of medicine. The incorporation of a risk predictive tool for intrapartum caesarean 
delivery would enable women and their caregivers to choose the most appropriate 
management plan for each woman.
Keywords: prediction model, caesarean delivery, personalised care
1. Introduction
The last three decades have witnessed an escalation in global Caesarean section 
rates. It is well recognised that there is an association between delivery by Caesarean 
section and both short and long-term maternal morbidity, particularly at an 
advanced stage in labour [1]. This association is significantly stronger in the setting of 
emergency Caesarean section than scheduled elective non-labour Caesarean delivery.
It is notable that post-operative complications, including haemorrhage and 
perioperative infection in women who undergo unplanned Caesarean delivery are 
significantly higher when compared to women who undergo elective Caesarean 
delivery [2].
Magann et al. [3] examined the outcomes regarding post-partum haemorrhage 
of over 4000 Caesarean section deliveries in Australia in their observational study. 
They determined that the incidence of post-partum haemorrhage in an emergency 
setting was 6.75% and the incidence in an elective setting was 4.74%.
A 2014 Cochrane review [4] examined the rates of post-partum sepsis for both 
intrapartum and elective caesarean sections. They identified 95 studies, which 
recruited over 15,000 women. They determined that the rates of wound infection 
were 9.7 and 6.8% respectively. As regards endometritis, the rates were 18.4% for 
intrapartum caesarean sections versus 3.9% for elective caesarean sections.
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It is important to also reference the association in particular between intra-
partum caesarean sections and maternal morbidity. The incidence of caesarean 
sections performed at full dilatation is increasing [5]. These deliveries are associated 
with an increase in maternal morbidity including visceral trauma, haemorrhage and 
extension of the wound [6].
The Archives of Obstetrics and Gynaecology published a review in 2017 which 
specifically aimed to enumerate the differences in complications experienced in 
women who underwent elective Caesarean delivery and those who underwent 
emergency Caesarean delivery [7].
This systematic review included nine individual studies. Inclusion criteria 
dictated that the studies had to be either a randomised control trial study or a 
controlled clinical trial study to perform a comparison of the morbidity and mortal-
ity between elective and emergency intrapartum Caesarean delivery.
The combined results demonstrated that the rates of infection, fever, urinary 
tract infection, wound dehiscence, disseminated intravascular coagulopathy, and 
reoperation of emergency Caesarean section were all much higher than those of 
elective Caesarean section.
A unifying sentiment that can dominate a woman’s post-natal course after an 
intrapartum Caesarean section delivery is the desire to anticipate this interven-
tion. Prenatal knowledge that a successful vaginal birth will not be achieved would 
obviate the labour-associated risks that frequently result in maternal or perinatal 
morbidity, and the dissatisfaction of having undergone a ‘trial’ of labour to no avail.
The Organisation for Economic Co-Operation and Development (OECD) 
reports that there has been a significant increase in Caesarean section delivery rates 
in most OECD countries between the years 2000 and 2015. The average rate has 
increased from 20 to 28%, although there does appear to have been a slow-down 
in the rate of growth in the past 5 years [8]. It is also notable that different hospi-
tals and regions within the same country can show significant variation in their 
Caesarean section rates. For example, Italy continues to show huge variation in the 
Caesarean delivery rates. High rates of Caesarean delivery appear to be driven by 
the southern region. Similar variations in rates between different regions are also 
observed in Spain [9].
Of note, the U.S. has shown a decline in its Caesarean delivery rate for the fourth 
consecutive year. Caesarean delivery rates in 2016 were 31.9%, which had fallen 
slightly from 32% in 2015. Prior to this, they had increased annually from 20.7% in 
1996 to a peak of 32.95 in 2009 [10].
On a global level, the Caesarean section rate over the past 30 years has escalated 
but interestingly, no associated significant maternal or perinatal benefits have been 
demonstrated [11–13].
This increase prompted The Lancet to compile a series on optimising the use of 
Caesarean section, which was published in October 2018. The authors of this review 
argued that the decision to perform a Caesarean section might be guided by the 
psychological or clinical needs of the mother, the clinical needs of the baby or by a 
combination of both [14].
However, where rates of Caesarean section exceed what is considered a ‘recom-
mended rate’ of 10–15% as per the World Health Organisation [15], there were three 
main drivers identified which were though to contribute to perceived over-use of 
this intervention. These were categorised broadly as health professionals; com-
munities (incorporating families, childbearing women and the broader society) and 
health care systems (comprising organisational design and cultures and financing).
As regards communities, families, childbearing women and the broader society, 
it was noted that women worldwide would not prefer to have a Caesarean section 
without a significant maternal or foetal indication [16]. This is in direct contrast to 
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the common perception that many women would choose a Caesarean section as a 
matter of preference [17].
Factors relating to health professionals highlighted that being male, being 
employed in a university-affiliated hospital and a fear of litigation were associated 
with an increased likelihood of an obstetrician performing a Caesarean section [14]. 
They also found Caesarean section might sometimes be used for convenience. This 
was particularly noted where both a combination of private and public work was 
performed in the same unit. The scheduling of elective Caesarean sections can allow 
commitments to public work being fulfilled while allowing the performance of 
private work on the same premises [18].
Of particular interest to clinicians is addressing the safe prevention of unwar-
ranted primary Caesarean section delivery. In March 2014, a joint consensus 
was issued by the Society for Maternal Fetal Medicine and American College of 
Obstetricians and Gynaecologists (ACOG). This addressed the importance of the 
safe prevention of primary Caesarean delivery and this was reaffirmed in 2016 
[19]. As previously mentioned, The Lancet has also highlighted the importance of 
addressing appropriate and safe use of Caesarean section in order to address the 
escalating rates worldwide [9].
This chapter will deal with the use of prediction models in medicine in order 
to address how best to antenatally predict the need for an intrapartum Caesarean 
section for a nulliparous woman. The clinical application of such a prediction model 
would ultimately be that those women issued with a high likelihood for intrapartum 
Caesarean delivery might opt for an elective Caesarean section with the associated 
decreased morbidity risks.
On a corollary to this is the point that many women would likely prefer the 
prospect of a trial of labour if they were assigned a low-risk for intrapartum 
caesarean delivery. Furthermore, this may allow women the opportunity to consider 
a less medicalised environment for birth for example in a midwifery-led unit. A 
review of the literature would suggest that the majority of women would opt for a 
vaginal delivery over a caesarean section. An Australian study which asked women 
to complete an antenatal questionnaire found that 93.5% of women would prefer a 
vaginal delivery over a caesarean section [20]. This showed very similar results to a 
Swedish-based study which found that only 8.2% of nulliparous women would pre-
fer to deliver by caesarean section [21]. Similar opinions were also found amongst 
women in Brazil and Chile, which are countries with traditionally high caesarean 
section rates [22–24]. The Genesis risk prediction model could empower women 
entering labour with a low predictive risk score for an intrapartum caesarean sec-
tion that they had a high likelihood of a desirable successful vaginal delivery.
I will outline the development and usage of prediction models in other areas 
of medicine and the research into various factors, which have been highlighted as 
predictive for Caesarean delivery. If achievable, the ability to predict the outcome of 
an attempt at first labour is highly desirable. It is apparent that the safe prevention 
of primary Caesarean delivery is an outcome, which would be welcomed by the 
international obstetric community.
2. Predictive models
2.1 Rationale for use of predictive models in healthcare
Certain decisions in healthcare require a detailed process in order to provide 
optimal care to patients. This can be complicated by a deficit in standardisation of 
processes, which aim to encompass the needs of multiple stakeholders.
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Various modelling tools can assist the decision-making process. Some of these 
aim to predict a clinical outcome, whereas others focus on identifying the patients 
who may be most at risk of developing a certain condition [25].
These tools are created using formulae that may assist in decision-making. These 
in turn can assist in resource planning and allocation in healthcare. Examples of 
such tools are prognostic and prediction models [26].
Prognostic models may have varied uses, including ‘guiding healthcare policy 
by generating global prediction scenarios; determining study eligibility of patients 
for new treatments; selecting appropriate tests and therapies in individual patient 
management including supporting decisions on withholding or withdrawing 
therapy’ [27].
The two main types of prognostic models seen in practice are those at the 
individual patient level and those at the patient population level. Individual patient 
models are used in suggesting advice for treatment and to provide consultation, 
which is patient-centered. Patient population models are more focused on the 
identification of discrepancies and trends amongst patient groups for a specific 
criterion [27].
Predictive modelling can be used to help identity patients who may be at high-
risk for a certain outcome, e.g. an intrapartum Caesarean delivery. Predictive 
modelling can also be used in order to manage healthcare resources by initiating 
appropriate interventions to prevent high-cost outcomes [28].
One such example which has been developed in clinical practice is the cardiovas-
cular disease risk assessment for primary prevention. The Framingham Heart Study 
looked at 7733 participants who had initially been free of coronary heart disease 
and were aged between 40 and 79 years. They found that the lifetime risk of being 
affected by coronary heart disease (CHD) for these participants by age 40 was 32% 
in women and 49% in men [29].
This highlighted the importance of cardiovascular disease risk assessment being 
performed from the age of 20 years of age or from a person’s first encounter with 
the healthcare system. This can then in turn predict those individuals who are at 
the most significant risk of cardiovascular disease. Identifiable risk factors included 
cigarette smoking, hypertension, diabetes mellitus, premature family history of 
cardiovascular disease, chronic kidney disease and obesity. These individuals can 
then be commenced on appropriate primary preventive therapies or receive alterna-
tive appropriate intervention. Predictive modelling acts on the basis of taking a 
proactive approach, i.e. the identification of trends and forecasting of events which 
may cause implications for stakeholders in healthcare [25].
There are several factors which need to be considered in the implementation of a 
new prediction model [30]. These include:
• The creation of a focus on the population as a whole and examining all aspects 
of healthcare
• An emphasis on change of behaviour in the longer-term
• The utilisation of data to create programs which aim to address learning, health 
status and individualised risk
• The development of health plan designs which act to support and incentivise
Providers of healthcare and patients are both motivated to achieve improved 
outcomes and this suggests that the use of these models is likely to increase with the 
added benefit of potential reduction in healthcare costs.
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For our purposes, accurate prediction of Caesarean delivery may allow consid-
eration being given to elective Caesarean delivery in the event of a woman being 
considered high risk for an intrapartum Caesarean delivery in order to reduce the 
incidence of specific maternal morbidities as aforementioned including infection, 
haemorrhage and the need for a repeat surgery. A low predictive risk score also 
empowers women who are keen on a successful vaginal delivery with the knowledge 
that they have a high likelihood of achieving same.
2.2 Use of predictive models in obstetrics
Historically, the field of obstetrics has been successful in developing prediction 
models but has been poor in fully validating and thus implementing them effec-
tively [31].
On a daily basis, we still use two examples of prognostic models in obstetrics, 
which were developed over 60 years ago. One such model is the Apgar score, which 
assesses newborn babies immediately after their birth. The other model is the 
Bishop score, which assesses the status of the cervix before and during induction 
of labour [32, 33]. Both of these models were developed in the 1950s–1960s and are 
still used clinically, likely due to their ease of use and continued relevance [31].
The Apgar score was re-examined and re-validated by a research group in Texas 
almost 50 years after its initial introduction. They reviewed the charts of more than 
150,000 deliveries over a 10 years period and found there was a significant correla-
tion between these babies’ 5 minute Apgar scores and neonatal mortality [34]. This 
score remains an easy and quick way to determine if resuscitation has been effective 
and has therefore survived the test of time [35].
The Bishop score assesses cervical dilatation, cervical effacement, cervical 
consistency, cervical position and foetal station. A higher score meant a woman 
was more likely to have a spontaneous onset of labour sooner. It is still in use today 
and can aid clinicians in deciding the most appropriate method of delivery for each 
woman. The work of Professors Apgar and Bishop essentially formed some of our 
earliest prediction models in obstetrics.
Only two thirds of the papers [62.4%, 164/263] in a large systematic review of 
prognostic models in obstetrics were found to have presented their models in such 
a way that external validation would be feasible [31]. This has been highlighted as a 
concern given the importance of validity in the development of such models.
Certain models can be too complex for routine clinical usage and this may lead 
to a reluctance on the part of the clinicians to accept them [36]. For example, the 
use of an electronic program to help predict those patients most in need of requir-
ing an influenza vaccination was found to be ineffective as it did not prove to be 
user-friendly. It is also important that models which have been developed are also 
validated in a new population as otherwise it may not be possible to generalise them 
to a different cohort of patients [37]. This is also known as impact analysis and this 
paper by Reilly et al. highlights that very few prediction models have undergone 
formal impact analysis or validation. This is essential in order for clinicians to know 
if the usage of such a model will have a positive or negative effect, i.e. is there a 
possibility that it will cause harm. The authors highlighted the benefit of having 
clinicians involved in the development and validation of such models before, during 
and after implementation.
There are limitations to the development and use of prediction models in 
obstetrics. It has been shown that internal validation is largely successful and the 
models have been shown to perform well under this setting. However, there has 
been a deficit of research into looking in to externally validating these predic-
tion models in a different cohort. Another limiting factor for clinical usage and 
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which was discussed in a commentary in the British Journal of Obstetrics and 
Gynaecology (BJOG) in 2016 is how interventions might be handled in a predic-
tion model [38]. This commentary highlighted the issues, which face clinicians in 
validating obstetric prediction models in order to effectively implement them in 
clinical practice. They specifically examined the area of pre-eclampsia and noted 
that a phenomenon described as the treatment paradox can occur; a strong predic-
tor of a common complication may trigger an effective treatment (e.g. commence-
ment of anti-hypertensive therapy) at an early stage and this will then prevent 
the occurrence of a certain proportion of adverse outcomes. This may result in the 
predictor, which triggered the treatment initially appearing poorer in its predictive 
performance [39, 40].
The BJOG review [38] further examined a prediction model which has been 
successfully validated for the predicting pre-eclampsia (PREP model-Development 
and validation of Prediction models for Risks of complications in Early-onset Pre-
eclampsia) [41] in order to ascertain what made it a successful process and high-
lighted certain factors which can aid validation. These included large sample size, 
standardisation of treatment or intervention, and the consideration to the initiation 
of treatment being an outcome itself, i.e. ‘When starting a treatment is likely to pre-
vent an adverse outcome, those who received the treatment could also be considered 
to have experienced the outcome’. These factors may aid obstetricians in validation 
of prediction models going forward and in handling the treatment paradox.
2.3 Use of predictive models in gynaecology
The field of gynaecology has also developed a new risk prediction model in 
recent times. A large cross-sectional international cohort study involved the par-
ticipation of 5020 patients from 22 centres [42]. This study developed and validated 
a risk prediction model to predict the risk of malignancy in adnexal masses using 
specific ultrasound features which are defined in the simple rules.
In 2008, the simple rules were described by the International Ovarian Tumour 
Analysis (IOTA) group [43]. These specific ultrasound features are known as either 
B-features (where tumours are likely benign) or M-features (where tumours are 
likely malignant).
In using the simple rules, and there are no specific features identified or if there 
is a conflict between the features, then the rules cannot be applied and the result is 
inconclusive. In this instance, it is recommended to classify the findings as having a 
higher risk of malignancy in order to increase the sensitivity for ovarian cancer [33].
The simple rules have been well received by clinicians and adopted by interna-
tional bodies such as the Royal College of Obstetricians and Gynaecologists [34]. 
Zimmerman et al. aimed to develop and validate a model based on the criteria 
laid down in the simple rules. When used as originally suggested, the simple rules 
aimed to categorise tumours as belonging to one of three distinct groups: benign, 
malignant, or inconclusive. Zimmerman et al. demonstrated that the simple rules 
could also be used to estimate the risk of malignancy in every adnexal mass. In this 
way, they can be applied to individual patients to optimise their own management 
[31]. The rules were found to be applicable in 76% (386/507) of the tumours, with 
a sensitivity of 95% (106/112) and a specificity of 91% (249/274). This risk predic-
tion model has the potential to be broadly accepted given its ease of use and the fact 
that it is based on standards which have already been accepted and are used by the 
gynaecological community. Several follow up studies [35, 36] have highlighted that 
the rules can be easily utilised by ultrasonographers and that the protocol can be an 
accurate test to diagnose ovarian cancer.
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2.4 Use of predictive models in other aspects of health care
Increasingly, attempts have been made to develop and validate prediction tools 
which aim to predict the risk of hospital readmission [44]. Interest in this area has 
evolved for a number of reasons. Of clinical importance is that an intervention 
while a patient remains in hospital may help to reduce readmission rates as those in 
need of additional care may receive it while still an inpatient. It also helps to target 
delivery of interventions which are resource-intensive to those with the greatest 
need [45]. This would result in a stratification of the risk of readmission, which 
may hold clinical relevance. In turn, this would allow for early information during 
a patient’s admission, which would allow the initiation of an intervention such as 
advanced discharge planning which could begin during the admission and before 
discharge from hospital. Models used should be accurate, clinically relevant, use 
easily obtainable data and be able to be used in large patient populations [46].
Covariates are used in risk prediction models. This is done with the aim of 
detecting a given outcome or to determine a defined period of time whereby an 
individual is thought to experience a specific outcome [47].
These predictors are varied and may encompass characteristics such as gender or 
age, biochemical markers, coronary artery deposits or specific genetic markers [48].
In the field of cardiology, prediction models include Framingham [49], SCORE 
[50], ASSIGN [51], EUROSCORE [52], PROCAM [53], and Wells’ scores [54].
Prediction models may assist individuals and their clinicians in deciding the 
most appropriate management plan or on the implementation or withholding of 
treatment or lifestyle interventions.
There is an increased desire to implement personalised care and because of this, 
research into prediction models is increasing [55]. In the current era of risk-tailored 
and personalised cardiovascular care, studies on prediction models are abundant. 
A recent statement of the American Heart Association on criteria for the phased 
evaluation of markers of cardiovascular risk underlines this. A key term in this 
statement was that ‘multivariable prediction models and cardiovascular markers 
should not (simply) be evaluated in isolation for their prediction abilities but rather 
on their added prediction contribution beyond existing or established predictors 
requiring a multivariable approach in design, conduct, analyses and reporting’ [56].
It is important that the development of prediction models should follow strict 
methodologic processes. New prediction models should detail their development 
process and highlight all their statistical calculations in order to allow researchers 
in the future to reproduce and validate their findings. Research into the relatively 
new field of biomarkers needs to determine their additional benefit to pre-existing 
models [57].
The selection of specific chemotherapy regimens is made based on examination 
of the outcomes for specific subtypes and specific types of malignant tumours, their 
likelihood to progress to metastases and their overall prognosis [58, 59]. The overall 
effectiveness of certain agents also means that the development of tiered strate-
gies has developed in order to overcome variations seen in the resistance of certain 
tumours [60].
This study examined the responses of chemotherapy agents cisplatin, carbo-
platin and oxaliplatin with certain gene signatures [61]. This group developed a 
machine-learning based prediction model, which aimed to predict the effectiveness 
of the agents above to certain gene signatures. This tailored treatment may result 
in an improved treatment response to an individual’s specific cancer biology which 
may result in reduced treatment duration or the minimum usage of chemotherapy 
agents to achieve a desired response [62].
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Cancer treatment is challenging as the disease can be complicated by genetic 
heterogeneity with differences in the genetic composition of tumours causing dif-
ferent responses to treatment [63].
The impact of this variance in genetic composition means that there may varied 
responses to treatment regimes. This means that the therapy may only benefit a 
small proportion of the patients treated [64]. In order to minimise the associated 
adverse effects which can occur with using these treatments, it is of particular 
benefit to patients with cancer to decide on the optimal treatment regime at the 
time of diagnosis [65].
Ubels et al. [65] developed the idea of simulated treatment learning (STL). 
This program assists in identifying the factors that can best predict treatment 
benefit and can be applied to gene expression datasets with two treatment arms 
and associated survival data. It works by identifying genetic similarities between 
patients from different groups to model how a particular patient would respond to 
an alternative treatment plan and is defined based on the expression of the genes in 
the tumour. Their work focused on patients with multiple myeloma and how best 
to predict the benefit of treatment. Multiple myeloma affects the bone marrow by 
causing abnormal multiplication of the plasma cells. The typical median survival 
is approximately 5 years [66]. Multiple myeloma is one of the known conditions 
where a difference in gene expression profiles is observed amongst patients [67]. 
This variation in genes expression means that identification of individual genetic 
signatures may be useful to help predict those who would benefit from STL.
3. Prediction of intrapartum caesarean section
3.1 Definition of intrapartum caesarean section
An intrapartum Caesarean section is a Caesarean section, which occurs dur-
ing the course of labour. According to the American College of Obstetricians 
and Gynaecology, the most common indications for primary Caesarean delivery 
include, in order of frequency, labour dystocia, abnormal foetal heart rate tracing, 
foetal malpresentation, multiple gestation, and suspected foetal macrosomia [19].
3.2 Labour dystocia and associated risk factors
The progression of labour and recognition of prolonged labour can heavily 
influence the management of labour and the need for intrapartum Caesarean sec-
tion. Prolonged labour has been defined as true labour dystocia and may be caused 
by either obstruction of labour or contractions, which are inadequate in number or 
strength. Prolonged labour is the main indication for performing an intrapartum 
Caesarean section in nulliparous patients [68].
Labour dystocia may be recognised in either the first or the second stage of 
labour. It has been reported to affect 21–37% of nulliparous women and 2–8% of 
multiparous women [69–71]. It has been attributed to several factors including 
macrosomia, reduced capacity of the pelvis, inefficient uterine contractions or 
a combination of these factors [72]. There are multiple studies in the literature 
examining the causes of labour dystocia.
The association between foetal macrosomia and labour dystocia is well described. 
Galvin et al. have previously looked at the accuracy of antenatal detection of macro-
somia >4000 g and subsequent delivery outcomes in the absence of antenatal inter-
vention [73]. They noted ultrasound sensitivity and specificity of 41.2 and 94.1% 
respectively for detecting macrosomia >4000 g. The positive predictive value (PPV) 
9Prediction of Caesarean Delivery
DOI: http://dx.doi.org/10.5772/intechopen.87311
and negative predictive value (NPV) were 57.5 and 89.1% respectively. Their conclu-
sion was that the capacity of ultrasound to detect foetal macrosomia is limited.
This finding is also reflected in a study by Chuahan et al. [74]. This group con-
ducted a review of international articles from studies containing a sample size of at 
least 1000 cases in order to determine the prevalence and accuracy of determining 
macrosomia. The probability of detecting a macrosomic baby in a term, low-risk 
baby is ranged from 15 to 79% sonographically and 40–52% with clinical examina-
tion. They determined that the detection of macrosomia is reliable sonographically 
and clinically if the incidence of macrosomia is at least 20% in the relevant cohort.
The influence of foetal head circumference on delivery outcome has been exten-
sively studied. Kennelly et al. suggested in 2003 that foetal head circumference 
>37 cm is a good predictor of prolonged labour in their study which examined 423 
nulliparous women with a singleton cephalic presentation who had a spontaneous 
onset of labour [75]. They determined that as birth weight and foetal head circum-
ference increased, there was an associated increase in mean duration of labour, 
duration of second stage of labour and usage of oxytocin (P < 0.001).
Elvander et al. conducted a population based register study, which was pub-
lished in 2011 [76]. This examined a total of 265,456 singleton term neonates who 
were born to nulliparous women between 1999 and 2008 in Sweden. This data was 
extrapolated following analysis of the Swedish Medical Birth Register. The inves-
tigators examined factors including labour dystocia, instrumental delivery, foetal 
distress and Caesarean section. They found that the prevalence of each outcome 
increased as the circumference of the foetal head increased. In the case of Caesarean 
section in particular, the odds ratio was 1.22 (95% CI 1.04–1.42), indicating that 
a large foetal head (39–41 cm) is associated with labour dystocia and subsequent 
intrapartum Caesarean section. Valsky et al. also highlighted prolonged second 
stage of labour (greater than 110 minutes) and increasing foetal head circumfer-
ence as risk factors for obstetric anal sphincter injury in nulliparous women. They 
showed through logistic regression that a head circumference greater than 35.5 cm 
and a second stage of labour greater than 110 minutes increased the odds of obstet-
ric anal sphincter injury by a factor of 5.32 [77].
The position of the foetal head has also been extensively examined as a risk fac-
tor for Caesarean section. Occipito-posterior position is identified in approximately 
15–20% of women before labour at term [78, 79]. The majority 90–95% undergo 
rotation during labour to an occipito-anterior position [80, 81]. The presence of an 
occipito-posterior position at delivery has been extensively examined with respect 
to maternal morbidity and an increased risk for Caesarean delivery [82–85].
Maternal age has been strongly associated with delivery by Caesarean section. 
Women aged 40 and over are more than twice as likely to deliver by Caesarean as 
women under age 20 [8]. Advanced maternal age has been shown to be associ-
ated with an increased risk of obesity [86], diabetes and hypertensive disease 
[87–89] and interventions including delivery by Caesarean section [90–94]. There 
is evidence demonstrating that the rate of Caesarean sections performed on an 
elective basis in the absence of a strong medical indication increases with advancing 
maternal age [95, 96]. Maternal age has also been shown to be an independent risk 
factor for Caesarean delivery [97].
Maternal BMI has also been associated with delivery by Caesarean section. 
Young and Woodmansee in 2003 published the results of an 8-year review of 
women who delivered in their practice. They found that primiparous woman who 
had a BMI of over >30 kg/m2 were six times more likely to undergo an intrapartum 
Caesarean delivery for labour dystocia than those primiparous women whose BMI 
was <20 kg/m2. This difference in mode of delivery persisted even when results were 
controlled for gestational age, birth weight, maternal height and maternal age [98].
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Algovik et al. performed a retrospective analysis of the Swedish Birth Registry 
and identified 104 women in 47 families where at least two of sisters had undergone 
intrapartum Caesarean delivery at term attributed to labour dystocia during the 
course of a first labour [72]. A genetic basis for labour dystocia was sought, which 
identified strong evidence of linkage at chromosome 12p12 and at five other sepa-
rate loci, which may of significance. There was no specific prevalence data included 
in their report. The authors however were unable to identify a specific gene, which 
may be responsible for labour dystocia. Re-sequencing of oxytocin (OXT) and 
oxytocin receptor (OXTR) seemed to be obvious candidate genes for this analysis. 
However, they did not allow for identification of any potential causal mutations. 
Further studies with a larger study population were recommended.
Mittal et al. [99] have also performed genetic testing to establish a cause for 
arrest of labour. They obtained myometrium samples from 50 women who under-
went primary Caesarean delivery in a prospective study. All of these women had 
had a spontaneous onset of labour. They compared two groups of women. One 
group (n = 29) underwent Caesarean delivery due to either non-reassuring foetal 
status or foetal malpresentation. The second group (n = 21) underwent Caesarean 
delivery due to an arrest of labour. This was defined as women who had complete 
cervical dilatation but without continued foetal descent for greater than 1 hour. 
They identified over 400 different genes, which differed in women who experi-
ence an arrest in the descent of the foetal head during labour when compared with 
those who underwent Caesarean delivery for non-reassuring foetal status or foetal 
malpresentation. An over expression of certain inflammatory and biomarkers 
was identified in women who experience an arrest of descent including hypoxia 
inducible factor-1a, prostaglandin-endoperoxidase synthase 2 and interleukin-6. 
These factors were identified using micro-array. The authors did acknowledge that 
their study may be limited, as they could not establish a true causative effect, as 
this would require studies involving serial sampling in women, which would not be 
feasible. However, they recommended that this study may act as a framework for 
additional studies, which may address potential therapeutic interventions.
3.3 Model of care as a predictor of caesarean section rates
In many maternity settings worldwide, women can opt for obstetric or mid-
wifery-led care. A descriptive comparative Australian study examined the outcomes 
of women who opted for either midwifery-led care or standard hospital care, 
which incorporated more input from the obstetric team. The study found that more 
women who opted for midwifery-led care were very satisfied with their overall care 
during their pregnancy, labour and delivery than those who experienced standard 
hospital care (80% very satisfied versus 53.2%). However, the study found that 
there was no observable difference in the Caesarean delivery rate between the two 
groups [100].
A randomised controlled trial, also based in Australia, examined if there was a 
difference in the Caesarean delivery rate between women who were assigned stan-
dard hospital-based care or community led care. However, this study differed from 
the aforementioned descriptive study in that those who experienced community led 
care were under the joint collaborative care of both midwives and obstetricians. In 
this study, there was a significant difference in the Caesarean delivery rate between 
the two groups. The group that experienced community based care had a Caesarean 
section rate of 13.3% (73/550) and the group that had standard hospital based 
care had a Caesarean section rate of 17.8% (96/539). The difference remained after 
controls were implemented for other known factors which may have contributed to 
their Caesarean sections (OR = 0.6, 95% CI 0.4–0.9, P = 0.02) [101].
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A Canadian randomised controlled trial in 1996 examined the outcomes of 
nearly 200 low-risk women who were assigned randomly to either nurse-midwife 
led care or physician (family doctor and obstetrician) led care. The nurse-midwife 
led group had a Caesarean deliver rate of 4% in comparison with 15.1% in the 
physician group. There were also lower rates of epidural and episiotomy usage in the 
nurse-midwife led group [102].
Their relatively low numbers may explain the variations in the reported findings 
of these studies. The British Journal of Obstetrics and Gynaecology performed a 
systematic review in 2005 of randomised controlled trials in which the study inter-
vention was characterised as midwifery-led care versus standard obstetric care. This 
review highlighted seven trials, including 9148 women. In general, they found that 
women who experienced midwifery-led care in their antenatal and labour courses 
were less likely to have interventions in labour including induction of labour, use of 
oxytocin, epidural usage, CTG monitoring, operative vaginal delivery and episi-
otomy. However there was no difference in the Caesarean delivery rate between the 
two groups (OR 0.91; 95% CI 0.78–1.05) and there were no observable differences 
in infant and maternal outcomes. [103].
The British Journal of Obstetrics and Gynaecology published the ‘Birthplace 
study’ in 2011 [104]. This large prospective cohort-based study of 64,538 women 
had the objective of comparing perinatal outcomes, maternal outcomes and 
interventions in labour by planned place of birth at the start of care in labour for 
women with low risk pregnancies. This study took place in NHS care facilities across 
England. Recruitment criteria included both nulliparous and multiparous women. 
The Birthplace study concluded that a choice of birth setting was optimal for 
women with low risk pregnancies and determined that those women who delivered 
in a midwifery unit or multiparous women who delivered at home experienced 
fewer interventions with no change in perinatal outcomes. When specifically 
comparing intrapartum Caesarean section rates, intended place of birth (with this 
decision made antenatally) varied significantly. Those who intended to give birth 
in an obstetric unit had an intrapartum Caesarean section rate of 11.1% (99% CI 
9.5–13.0). This compared with those who intended to give birth in a midwifery unit 
or at home having intrapartum caesarean delivery rates of 3.5% (99% CI 2.8–4.2) 
and 2.8% (99% CI 2.3–3.4) respectively.
3.4 External pelvimetry
It is estimated that 600,000 worldwide die annually as a result of complications 
of pregnancy [105]. Of these, approximately 25% are thought to be attributable to 
cephalo-pelvic disproportion [105–108]. Cephalopelvic disproportion is defined 
as a mismatch between the size of the foetal head and size of the maternal pelvis, 
resulting in ‘failure to progress’ in labour for mechanical reasons [109]. It is there-
fore of significant global public health benefit to be able to accurately predict and 
detect these women who are more likely to require Caesarean section and to be 
in a position to predict this prior to labour onset. This is of particular importance 
in areas where Caesarean section is not feasible in order to be able to refer these 
women to units where Caesarean section may be performed. In the developed world 
where access to Caesarean section is easier, it is also desirable to be in a position 
to accurately predict those women who may require same, thus the importance of 
development of prediction models for Caesarean section.
External pelvimetry was the first known technique used to predict cephalopelvic 
disproportion [110, 111]. It involves the usage of a pelvimeter (e.g. Breisky pelvim-
eter). August Briesky was an Austrian gynaecologist who developed a pelvimeter 
in the nineteenth century in order to aim to accurately measure the dimensions of 
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the female pelvis. A prospective cohort study published in the British Journal of 
Obstetrics and Gynaecology in 2000 by Liselele et al. [110] outlined the findings 
of 605 nulliparous women carried out in four hospitals in Zaire. They assessed 
maternal height and pelvimetry at the third trimester antenatal visit in order to 
predict women at risk for cephalo-pelvic disproportion with subsequent increased 
risk of Caesarean section. They considered women with a height less than 150 cm 
and/or external pelvic distances less than the 10th centile (<9.5 cm) for the popula-
tion to be at highest risk. A height gauge was used to ascertain maternal height and 
pelvimetry was assessed externally using a Breisky pelvimeter. They considered 
cephalopelvic disproportion to be present in 42 women. Their analysis showed that 
maternal height less than 150 cm and/or transverse diagonal of the Michaelis sacral 
rhomboid area less than 9.5 cm were most likely to be associated with cephalopelvic 
disproportion and labour dystocia (odds ratio of 2.2 [95% CI 0.9–5.4] and 6.5 [95% 
CI 3.2–13.2], respectively]. They also showed a positive predictive value of 24% [95% 
CI 2–8 to 5–8]) [110]. The transverse diagonal of the Michaelis sacral rhomboid area 
assessed by pelvimetry was noted to be of significant importance in the development 
of a model. The authors of this study recommended external validation of this model 
in a separate cohort before it becomes implemented in clinical practice. With a PPV 
of 24% this did not translate into a worthy research pursuit in high resource income 
setting. However, it is worth considering in the low resource setting where timely 
access to skilled birth attendants may be considerably restricted.
In 2007, Rozenholc et al. [112] performed another prospective cohort study spe-
cifically incorporating the measurement of the transverse diagonal of the Michaelis 
sacral rhomboid area which had been noted to be predictive by Liselele et al. previ-
ously, along with other anthropometic measurements including maternal height. 
This study looked at 807 nulliparous term women at term who completed a trial of 
labour and delivered a singleton fetus with a cephalic presentation. Ninety-eight 
women (12.1%) were found to have labour dystocia. They concluded the combina-
tion of the maternal height with the transverse diagonal of the Michaelis sacral 
rhomboid area could identify, before labour, more than half of the cases of dystocia 
in nulliparous women, therefore being a useful prediction model for prediction of 
Caesarean section.
3.5 X-ray pelvimetry
X-ray can also be used to assess pelvimetry. This is usually done by measuring 
the pelvic outlet, pelvic inlet and mid-pelvis using conventional x-rays with an 
anterior-posterior and a lateral view [113]. A Cochrane review published in 2017 
identified a total of 1159 women who had participated in five separate trials. All 
five of these trials used X-ray pelvimetry in pregnancy [114]. This review found 
that there was insufficient evidence to support the routine use of X-ray pelvimetry 
for assisting with decision making in determining the most appropriate mode of 
delivery for women. They concluded that women who underwent an X-ray pelvim-
etry may have an increased likelihood of undergoing a Caesarean section without 
any improved benefits for the woman or baby.
3.6 MRI pelvimetry
The usage of MRI has now been applied to pelvimetry. This has potential advan-
tages including the fact that there is no exposure of mother or fetus to radiation and 
the higher calibre of the quality of images makes it easier to calculate the volume of 
the maternal pelvis and the foetal head [115].
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Sporri et al. in their prospective observational study published in 2002 also 
determined that the efficacy of MRI for clinical use in dystocia is limited and rec-
ommended further research in order to determine the most appreciate anatomical 
landmarks which should be examined [116].
In 2004, Zaretsky et al. published their findings on MRI assessment of pel-
vimetry and its usage in the prediction of labour dystocia in another prospective 
study. This involved performing an MRI on 101 nulliparous women who were 
scheduled for an induction of labour for post-term pregnancy (>42 weeks). They 
found that MRI is accurate at predicting women who are at significant risk for 
labour dystocia but it is not of significant benefit when compared with other 
methods of pelvimetry [117].
3.7 Models for predicting vaginal birth after caesarean section
There is a significant body of research, which has examined the ability to predict 
a successful vaginal birth after a previous Caesarean section (VBAC).
The National institute of Child Health and Human Development Maternal-Fetal 
Medicine Units Network created a registry between 1999 and 2002 that incorpo-
rated the pregnancy outcomes of women who delivered at their 19 units. Using this 
data, a prediction model was developed to provide individual risk of probability of 
a successful VBAC for women with a singleton, cephalic presentation fetus at term 
who had experienced one prior Caesarean section. The data of 11,856 women were 
analysed. The key predictors include maternal BMI, maternal age, body mass index, 
ethnicity (Caucasian women having higher success rates), timing of the vaginal 
delivery in relation to the Caesarean, history of vaginal delivery and indication for 
the prior Caesarean [118].
The model has been successfully validated by this group and in several other 
cohorts [119–121].
3.8 Conjugate models to predict labour dystocia
Kim et al. in their prospective observational study published in 2010 examined 
clinical and ultrasonographic parameters for predicting the risk of intrapartum 
Caesarean delivery in nulliparous women [122].
These investigators recruited 453 women and performed clinical and ultraso-
nographic assessments at 37 weeks’ gestation. Fifty-seven (12.6%) of these par-
ticipants had an intrapartum Caesarean delivery. They analysed the importance of 
clinical parameters including maternal age, maternal height, maternal weight and 
Bishop score. Ultrasonographic parameters documented included foetal biparietal 
diameter, abdominal circumference, estimated foetal weight, amniotic fluid index 
and cervical length. Univariate analysis was used to confirm normal distribution. 
This was conducted using the Student’s t-test and Mann-Whitney U test amongst 
others. Multiple logistic regression analysis was utilised to identify which param-
eters were most associated with primary Caesarean delivery.
The five most significant parameters in predicting the risk of Caesarean deliv-
ery in nulliparous women were as follows: Maternal age OR 1.19 (95% confidence 
interval [CI], 1.09–1.30], P < 0.0001; maternal height (cm) OR 0.89 (95% confi-
dence interval [CI], 0.84–0.95), P 0.001; foetal abdominal circumference (cm) OR 
1.55 (95% confidence interval [CI], 1.23–1.97), P < 0.0001 and estimated foetal 
weight (g) OR 1.002 (95% confidence interval [CI], 1.001–1.004), P < 0.000. A 
prediction model was developed based on these significant parameters. The model 
was constructed using stepwise forward logistic regression analysis of the potential 
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predictors identified and the authors concluded that this could be of benefit in 
assisting decision-making around the most appropriate mode of delivery for 
women.
This study was designed as a prospective observational study with a sample 
size of 453 women. However, it should be noted that the authors did not consider 
examine BMI as a potential predictor. This has been shown by many studies in the 
literature, some of which have already been mentioned [98, 123] in this literature 
review as being highly predictive for intrapartum Caesarean delivery. The authors 
also cautioned that the predictive performance of the model might be overstated as 
its measures of discrimination are derived from the same analysis that was used to 
derive the model. They recommended further studies to validate this model in other 
study populations.
Mazouni et al. also developed and validated a nomogram to predict the risk of 
Caesarean delivery in macrosomic infants [124]. This was developed using the data 
collated from 246 women initially and validated in a further study of 206 women in 
Marseille, France. Interestingly, this study also included multiparous women. The 
final key predictors, which were incorporated into the nomogram, were: mater-
nal age (p = 0.01), maternal height (p = 0.02), parity (p < 0.001), and previous 
Caesarean section (p = 0.009). This study did not examine any ultrasonographic 
details and instead it retrospectively examined the maternal data of women who 
had delivered a baby >4000 g.
Burke et al. published in 2017 a similar conjugate model [125] that represents the 
predecessor for the subject of this thesis. The genesis study was a prospective obser-
vational study, which recruited 2336 low-risk nulliparous women from the island 
of Ireland from October 2012 to June 2015. These women attended for ultrasound 
assessment and collection of maternal anthropometric data from 38 + 0 weeks of 
pregnancy until 40 + 6 weeks of pregnancy and their delivery outcomes were later 
collated. Genesis found that five parameters were noted to be the most significant 
predictors of risk of a nulliparous women undergoing intrapartum Caesarean 
section delivery. These 5 parameters were advancing maternal age OR, 1.21 (95% 
confidence interval [CI], 1.09–1.34), P = .0005; increasing maternal BMI OR, 
1.29 (95% CI, 1.17–1.42), P < 0.0001; shorter maternal height OR, 1.72 (95% CI, 
1.54–1.92), P < 0.0001; larger foetal HC OR, 1.27 (95% CI, 1.13–1.42), P = 0.0001; 
and larger foetal AC OR, 1.23 (95% CI, 1.1–1.37) P = .0004.
These five predictors were then used to develop a nomogram to individually cal-
culate each nulliparous woman’s risk for requiring intrapartum Caesarean delivery.
4. Conclusions
We have highlighted the benefits of risk prediction models in many aspects of 
healthcare. We know from our own reading that these models have been developed 
in the field of obstetrics and particularly with the interest of predicting intrapartum 
caesarean delivery.
However, we are still awaiting a validated successful model, which may be used 
in clinical practice. We have also not identified any research studies examining the 
usage of Artificial Intelligence to aid with risk prediction or any randomised trials 
reviewing the merits of elective Caesarean delivery versus trial of labour in the 
event of cephalo-pelvic disproportion.
A focus group amongst expectant first-time mothers in our unit confirmed that 
women would be keen on the introduction of a risk predictive tool, which would be 
individualised for each woman. They felt that this would aid them in their decision-
making and birth planning.
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